
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Gang Xu, Ying Li, Shengyuan Zhang, et al.
Cell Research (2021) Vol. 31, Iss. 12, pp. 1230-1243
Open Access | Times Cited: 86
Gang Xu, Ying Li, Shengyuan Zhang, et al.
Cell Research (2021) Vol. 31, Iss. 12, pp. 1230-1243
Open Access | Times Cited: 86
Showing 1-25 of 86 citing articles:
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses
Shufen Li, Yulan Zhang, Zhenqiong Guan, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 201-214
Open Access | Times Cited: 53
Shufen Li, Yulan Zhang, Zhenqiong Guan, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 201-214
Open Access | Times Cited: 53
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 18
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 18
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Wenjing Gu, Hui Gan, Yu Ma, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Wenjing Gu, Hui Gan, Yu Ma, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 50
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 50
Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
Gang Xu, Yezi Wu, Tongyang Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Gang Xu, Yezi Wu, Tongyang Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review
Yan Huang, Qiong Ling, Anne Manyande, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 40
Yan Huang, Qiong Ling, Anne Manyande, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 40
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury
Yan Li, Chengyu Zou, Chen Chen, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 32
Yan Li, Chengyu Zou, Chen Chen, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 32
Targeting RIPK1 kinase for modulating inflammation in human diseases
Wanjin Li, Junying Yuan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Wanjin Li, Junying Yuan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo
Stefanie M. Bader, James P. Cooney, Reet Bhandari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Stefanie M. Bader, James P. Cooney, Reet Bhandari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1991-1991
Open Access | Times Cited: 38
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1991-1991
Open Access | Times Cited: 38
Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection
Xiang Gao, Shengyuan Zhang, Jizhou Gou, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. 418-427
Open Access | Times Cited: 35
Xiang Gao, Shengyuan Zhang, Jizhou Gou, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. 418-427
Open Access | Times Cited: 35
Lung Organoids—The Ultimate Tool to Dissect Pulmonary Diseases?
Veronika Bosáková, Marco De Zuani, Lucie Sládková, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30
Veronika Bosáková, Marco De Zuani, Lucie Sládková, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30
Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice
Hudan Pan, Jinlian He, Zifeng Yang, et al.
Phytomedicine (2023) Vol. 116, pp. 154858-154858
Open Access | Times Cited: 19
Hudan Pan, Jinlian He, Zifeng Yang, et al.
Phytomedicine (2023) Vol. 116, pp. 154858-154858
Open Access | Times Cited: 19
SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1
Budhadev Baral, Vaishali Saini, A Tandon, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1596-1617
Closed Access | Times Cited: 18
Budhadev Baral, Vaishali Saini, A Tandon, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1596-1617
Closed Access | Times Cited: 18
Involvement of regulated cell deaths in aging and age-related pathologies
Laura Della Torre, Antonio Beato, Vincenza Capone, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102251-102251
Open Access | Times Cited: 7
Laura Della Torre, Antonio Beato, Vincenza Capone, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102251-102251
Open Access | Times Cited: 7
Cytokines and microRNAs in SARS-CoV-2: What do we know?
Fahimeh Zamani Rarani, Bahman Rashidi, Mohammad Hassan Jafari Najaf Abadi, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 219-242
Open Access | Times Cited: 25
Fahimeh Zamani Rarani, Bahman Rashidi, Mohammad Hassan Jafari Najaf Abadi, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 219-242
Open Access | Times Cited: 25
NLRP3 Inflammasome Mediates Silica-induced Lung Epithelial Injury and Aberrant Regeneration in Lung Stem/Progenitor Cell-derived Organotypic Models
Hong Zhou, Qun Zhang, Wen Huang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 6, pp. 1875-1893
Open Access | Times Cited: 14
Hong Zhou, Qun Zhang, Wen Huang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 6, pp. 1875-1893
Open Access | Times Cited: 14
Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
Hui Han, Rong‐Hua Luo, Xin‐Yan Long, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 6
Hui Han, Rong‐Hua Luo, Xin‐Yan Long, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 6
Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study
P Clot, Christine Farenc, Benjamin T. Suratt, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
P Clot, Christine Farenc, Benjamin T. Suratt, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
Kunyu Shi, Jifa Zhang, Enda Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 14971-14999
Closed Access | Times Cited: 21
Kunyu Shi, Jifa Zhang, Enda Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 14971-14999
Closed Access | Times Cited: 21
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection
Aleksandra Drelich, Kempaiah Rayavara, Jason Hsu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1011777-e1011777
Open Access | Times Cited: 4
Aleksandra Drelich, Kempaiah Rayavara, Jason Hsu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1011777-e1011777
Open Access | Times Cited: 4
Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms
Mingxing Tang, Shumin Liao, Jing Qu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 19
Mingxing Tang, Shumin Liao, Jing Qu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 19
The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Yajuan Feng, Kang Tang, Qi Lai, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 17
Yajuan Feng, Kang Tang, Qi Lai, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 17